Home › Juvenile Arthritis › North Carolina
Juvenile Arthritis clinical trials in North Carolina
3 studies for Juvenile Arthritis are looking for participants at sites in North Carolina.
Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).
- Levine Childrens Hospital, Charlotte
RecruitingPhase 1
Ages 2 to 17 · All sexes · Updated Nov 9, 2026 · NCT06751238Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- University of North Carolina at Chapel Hill, Chapel Hill
- Levine Children's Hospital / Carolinas Medical Center, Charlotte
- Duke Children's Hospital & Health Center, Durham
- and 1 more
RecruitingObservational study
Up to age 21 · All sexes · Updated Oct 21, 2026 · NCT02418442A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- University of North Carolina - Children's Hospital /ID# 259286, Chapel Hill
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 1, 2026 · NCT06100744From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.